相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?
Yingyao Chen
INTEGRATIVE MEDICINE RESEARCH (2022)
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
J. Wei et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Human microbiome and metabolic health: An overview of systematic reviews
Nathalie Michels et al.
OBESITY REVIEWS (2022)
Chinese Medicine as an Adjunctive Treatment for Gastric Cancer: Methodological Investigation of meta-Analyses and Evidence Map
Cuncun Lu et al.
FRONTIERS IN PHARMACOLOGY (2022)
A new taxonomy was developed for overlap across 'overviews of systematic reviews': A meta-research study of research waste
Carole Lunny et al.
RESEARCH SYNTHESIS METHODS (2022)
The application of AMSTAR2 in 32 overviews of systematic reviews of interventions for mental and behavioural disorders: A cross-sectional study
Karina Karolina De Santis et al.
RESEARCH SYNTHESIS METHODS (2022)
Where to prospectively register a systematic review
Dawid Pieper et al.
SYSTEMATIC REVIEWS (2022)
Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map
Ting-ting Lu et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2022)
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Cong Huang et al.
HEALTH RESEARCH POLICY AND SYSTEMS (2022)
More Thoughts than Answers: What Distinguishes Evidence-Based Clinical Practice Guidelines from Non-evidence-Based Clinical Practice Guidelines?
Xiaomei Yao et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Authors should clearly report how they derived the overall rating when applying AMSTAR 2-a cross-sectional study
Dawid Pieper et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Value-Based Healthcare in Urology: A Collaborative Review
Chanan Reitblat et al.
EUROPEAN UROLOGY (2021)
Unlocking the Mystery of the Therapeutic Effects of Chinese Medicine on Cancer
Shao-Hsiang Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Nearly 80 systematic reviews were published each day: Observational study on trends in epidemiology and reporting over the years 2000-2019
Falk Hoffmann et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study
Cuncun Lu et al.
PHYTOMEDICINE (2021)
An epidemic of redundant meta-analyses
Celine Chapelle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Guanghui Zhu et al.
FRONTIERS IN PHARMACOLOGY (2021)
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Global mapping of overviews of systematic reviews in healthcare published between 2000 and 2020: a bibliometric analysis
Konstantinos I. Bougioukas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Clinical Epidemiology in China series. Paper 3: The methodological and reporting quality of systematic reviews and meta-analyses published by China' researchers in English-language is higher than those published in Chinese-language
Liujiao Cao et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis
Fanming Kong et al.
FRONTIERS IN PHARMACOLOGY (2021)
The effect of kanglaite injection in combination with gefitinib versus gefitinib alone in patients with nonsmall cell lung cancer: A meta-analysis
He Hailang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Kanglaite Injection Combined with Chemotherapy versus Chemotherapy Alone for the Improvement of Clinical Efficacy and Immune Function in Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Jianxia Wen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs
Xiaoming Huang et al.
PHYTOMEDICINE (2020)
Error rates of human reviewers during abstract screening in systematic reviews
Zhen Wang et al.
PLOS ONE (2020)
Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs
Juan Li et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Guidance for overviews of reviews continues to accumulate, but important challenges remain: a scoping review
Michelle Gates et al.
SYSTEMATIC REVIEWS (2020)
Reporting of Multi-Arm Parallel-Group Randomized Trials Extension of the CONSORT 2010 Statement
Edmund Juszczak et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Industry sponsorship and research outcome: systematic review with meta-analysis
Andreas Lundh et al.
INTENSIVE CARE MEDICINE (2018)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Selecting and implementing overview methods: implications from five exemplar overviews
Alex Pollock et al.
SYSTEMATIC REVIEWS (2017)
Kanglaite injection combined with hepatic arterial intervention for unresectable hepatocellular carcinoma: A meta-analysis
Fei Fu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma
Xiaohong Liu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation-induced tumor growth
Xinli Huang et al.
MOLECULAR MEDICINE REPORTS (2014)
Kanglaite Injection Plus Chemotherapy Versus Chemotherapy Alone for Non-Small Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis
Xuemei Liu et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2008)
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research
JAC Sterne et al.
STATISTICS IN MEDICINE (2002)